Commentary| Volume 74, 104716, June 2023

Cryopreservation of ovarian tissue as fertility preservation in young women with multiple sclerosis before stem cell transplantation



      Women of fertile age who receive autologous hematopoietic stem cell transplantation (AHSCT) due to multiple sclerosis (MS) are at risk of loss of ovarian function and infertility because of the conditioning regimen with alkylating agents.


      To present our data on fertility preservation by ovarian tissue cryopreservation (OTC) in young women with MS before AHSCT.


      Retrospective, observational cohort study


      Eight women had OTC. After AHSCT four had premature ovarian insufficiency (POI), and two of these had autotransplantation of their cryopreserved ovarian tissue. Both women regained ovarian function, and a spontaneous pregnancy was achieved resulting in the delivery of a healthy baby.


      OTC preserves fertility in young women with MS at risk of POI


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cavalla P.
        • Rovei V.
        • Masera S.
        Fertility in patients with multiple sclerosis: current knowledge and future perspectives.
        Neurol. Sci. 2006; 27: 231-239
        • Dolmans M.M.
        • von Wolff M.
        • Poirot C.
        • et al.
        Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers.
        Fertil. Steril. 2021; 115: 1102-1115
        • Khattak H.
        • Malhas R.
        • Craciunas L.
        • et al.
        Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.
        Hum. Reprod. Update. 2022; (Feb 24 [online ahead of print])
        • Kristensen S.G.
        • Wakimoto Y.
        • Colmorn L.B.
        • et al.
        Use of cryopreserved ovarian tissue in the Danish fertility preservation cohort.
        Fertil. Steril. 2021; 116 (Oct): 1098-1106
        • Lambertini M.
        • Del Mastro L.
        • Pescio M.C.
        • et al.
        Cancer and fertility preservation: international recommendations from an expert meeting.
        BMC Med. 2016; 14
        • Meirow D.
        Reproduction post-chemotherapy in young cancer patients.
        Mol. Cell. Endocrinol. 2000; 169: 123-131
        • Muraro P.A.
        • Pasquini M.
        • Atkins H.L.
        • et al.
        Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis.
        JAMA Neurol. 2017; 74: 459-469
        • Oktay K.
        • Karlikaya G.
        Ovarian function after transplantation of frozen, banked autologous ovarian tissue.
        N. Engl. J. Med. 2000; 342: 1919
        • Oktay K.
        • Marin L.
        • Bedoschi G.
        • et al.
        Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data.
        Fertil. Steril. 2022; 117: 181-192
        • Rosendahl M.
        • Schmidt K.T.
        • Ernst E.
        • et al.
        Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique.
        Reprod. Biomed. Online. 2011; 22: 162-171
        • Rush C.A.
        • Atkins H.L.
        • Freedman M.S.
        Autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis.
        Cold Spring Harb. Perspect. Med. 2019; 9: 1-15
        • Sepúlveda M.
        • Ros C.
        • Martinez-Lapiscina E.H.
        • et al.
        Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: a pilot study.
        Mult. Scler. 2016; 22: 564-568